MEDI-3039

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameMEDI-3039

Drug Alias NameMEDI-3039

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTumor necrosis factor receptor superfamily member 10B agonists

TargetsTumor necrosis factor receptor superfamily member 10B

Therapy Area/IndicationsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedimmune

China Registration ClassN/A

Active CompaniesMedimmune

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A